FindTrial
Sign In

The effect of esketamine as ropivacaine adjuvant on the efficacy of ultrasound-guided supraclavicular nerve block: a randomized controlled study

The effect of esketamine as ropivacaine adjuvant on the efficacy of ultrasound-guided supraclavicular nerve block: a randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200059371
Enrollment
Unknown
Registered
2022-04-28
Start date
2022-04-30
Completion date
Unknown
Last updated
2025-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper limb surgery

Interventions

Trial group:Esketamine as ropivacaine adjuvant
Control group:Ropivacaine (without the adjuvant esketamine)

Sponsors

Second Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Ages 18-65, American Society of Anesthesiologists physical status I-III; 2. Elective upper extremity surgery; 3. BMI 18-35kg/m2.

Exclusion criteria

Exclusion criteria: 1. Study drug allergy, coagulopathy, puncture site infection; 2. History of chronic pain, long-term use of analgesics; 3. Presence of study-related neuropathy; 4. Severe hypertension or intracranial hypertension; 5. Those who do not cooperate or are unwilling to sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
Duration of pain relief;—

Secondary

MeasureTime frame
Blocking onset time;Duration of motor block;Postoperative Sedation and Analgesia Score;—

Countries

China

Contacts

Public ContactYun Wu

Second Affiliated Hospital of Anhui Medical University

wuyunanyi@163.com+86 138 6595 8254

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026